AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 18447210 — intervention group
Group type: COMPARATOR
Intervention: Routine acupuncture group
Number of subjects: 71
Study 16799310 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxidized regenerated cellulose
Number of subjects: 40
Study 16799310 — intervention group
Group type: COMPARATOR
Intervention: Fine mesh gauze treated with Furacin
Number of subjects: 40
Study 12684301 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal pillows (Breeze; Mallinckrodt Corporation; Minneapolis, MN)
Number of subjects: 39
Study 12684301 — intervention group
Group type: COMPARATOR
Intervention: Nasal mask (Contour; Respironics; Murrysville, PA)
Number of subjects: 39
Study 12684301 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal pillows
Number of subjects: 39
Study 12684301 — intervention group
Group type: COMPARATOR
Intervention: Nasal mask
Number of subjects: 39
Study 10866905 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil (0.5 microg. kg(‐1). min(‐1) IV during induction, reduced to 0.25 microg. kg(‐1). min(‐1) after intubation)
Number of subjects: 103
Study 10866905 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil
Number of subjects: 103
Study 10866905 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl (dose per usual practice of the anesthesiologist)
Number of subjects: 103
Study 10866905 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl
Number of subjects: 103
Study 9396415 — intervention group
Group type: EXPERIMENTAL
Intervention: Left Ventricular (LV) pacing alone
Number of subjects: 27
Study 9396415 — intervention group
Group type: EXPERIMENTAL
Intervention: Biventricular (BIV) pacing
Number of subjects: 27
Study 9396415 — intervention group
Group type: COMPARATOR
Intervention: Right Ventricular Apex (RVA) pacing
Number of subjects: 27
Study 9396415 — intervention group
Group type: COMPARATOR
Intervention: Right Ventricular Outflow Tract (RVOT) pacing
Number of subjects: 27
Study 1286654 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute aerobic exercise (AE) at 70% heart rate reserve for 40 minutes
Number of subjects: 48
Study 1286654 — intervention group
Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 48
Study 2580180 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril 25 mg twice a day + Hydrochlorothiazide 25 mg once or twice daily
Number of subjects: 22
Study 2580180 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril 50 mg twice a day + Hydrochlorothiazide 25 mg once or twice daily
Number of subjects: 22
Study 2580180 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril 50 mg once daily + Hydrochlorothiazide 25 mg once daily
Number of subjects: 22
Study 2580180 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril and Hydrochlorothiazide (long-term treatment, 11 months)
Number of subjects: 22
Study 2580180 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril and Hydrochlorothiazide
Number of subjects: 22
Study 31002614 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF)
Number of subjects: 10
Study 31002614 — intervention group
Group type: COMPARATOR
Intervention: Non-PRF (conventional placement)
Number of subjects: 10
Study 27964728 — intervention group
Group type: EXPERIMENTAL
Intervention: Organophosphate (chlorpyrifos 50% plus cypermethrin 5%)
Number of subjects: 42
Study 27964728 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 27964728 — intervention group
Group type: COMPARATOR
Intervention: Comparison of organophosphate to placebo
Number of subjects: 42
Study 27964728 — intervention group
Group type: COMPARATOR
Intervention: Both organophosphate and placebo
Number of subjects: 42
Study 24141953 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous cervical discectomy (PCD)
Number of subjects: 171
Study 24141953 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous cervical disc nucleoplasty (PCN)
Number of subjects: 171
Study 24141953 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of PCD and PCN (PCDN)
Number of subjects: 171
Study 24141953 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 171
Study 22571225 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-surgical debridement with systemic Azithromax (®) for 4 days
Number of subjects: 48
Study 22571225 — intervention group
Group type: COMPARATOR
Intervention: Non-surgical debridement without systemic antibiotics
Number of subjects: 48
Study 22571225 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-surgical debridement with or without systemic antibiotics
Number of subjects: 48
Study 20685496 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen 400 mg/Paracetamol 1000 mg
Number of subjects: 234
Study 20685496 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen 200 mg/Paracetamol 500 mg
Number of subjects: 234
Study 20685496 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 234
Study 18394014 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose HT (1 mg of 17beta-estradiol and 0.5 mg of NETA)
Number of subjects: 202
Study 18394014 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional-dose HT (2 mg of 17beta-estradiol and 1 mg of NETA)
Number of subjects: 202
Study 18394014 — intervention group
Group type: EXPERIMENTAL
Intervention: Tibolone (2.5 mg)
Number of subjects: 202
Study 18394014 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene (60 mg)
Number of subjects: 202
Study 18394014 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 202
Study 16166814 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy (45 Gy)
Number of subjects: 96
Study 16166814 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy (six cycles of CHOP every 21 days)
Number of subjects: 96
Study 16166814 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy
Number of subjects: 96
Study 14618037 — intervention group
Group type: EXPERIMENTAL
Intervention: Off-pump CABG (n = 100)
Number of subjects: 200
Study 14618037 — intervention group
Group type: COMPARATOR
Intervention: On-pump CABG (n = 100)
Number of subjects: 200
Study 10985613 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole 250 mg 3 times/d
Number of subjects: 20
Study 10985613 — intervention group
Group type: COMPARATOR
Intervention: Nalidixic acid 400 mg twice a day for 10 d
Number of subjects: 20
Study 9057077 — intervention group
Group type: EXPERIMENTAL
Intervention: Dobutamine (2.5-7.5 micrograms/kg body weight per min, n = 8)
Number of subjects: 17
Study 9057077 — intervention group
Group type: EXPERIMENTAL
Intervention: OPC-18790 (5-10 micrograms/kg body weight per min, n = 9)
Number of subjects: 17
Study 1394348 — intervention group
Group type: EXPERIMENTAL
Intervention: SR-diltiazem (120 mgs bid)
Number of subjects: 12
Study 1394348 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 3882657 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin stearate, 1.5 g, administered orally 1 hour before extraction
Number of subjects: 109
Study 3882657 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 109
Study 3882657 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin stearate, 1.5 g
Number of subjects: 109
Study 3882657 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin stearate and placebo
Number of subjects: 109
Study 31236826 — intervention group
Group type: EXPERIMENTAL
Intervention: CenteringPregnancy Group Prenatal Care (GPC) (N=498)
Number of subjects: 992
Study 31236826 — intervention group
Group type: COMPARATOR
Intervention: Individual Prenatal Care (IPC) (N=994)
Number of subjects: 992
Study 29683850 — intervention group
Group type: EXPERIMENTAL
Intervention: Lottery-based incentives (low-cost)
Number of subjects: 2532
Study 29683850 — intervention group
Group type: COMPARATOR
Intervention: Gain-framed incentives (low-cost)
Number of subjects: 2532
Study 29683850 — intervention group
Group type: EXPERIMENTAL
Intervention: Lottery-based incentives (high-cost)
Number of subjects: 2532
Study 29683850 — intervention group
Group type: COMPARATOR
Intervention: Gain-framed incentives (high-cost)
Number of subjects: 2532
Study 29683850 — intervention group
Group type: EXPERIMENTAL
Intervention: Loss-framed incentives (low-cost)
Number of subjects: 2532
Study 29683850 — intervention group
Group type: EXPERIMENTAL
Intervention: Loss-framed incentives (high-cost)
Number of subjects: 2532
Study 26260784 — intervention group
Group type: EXPERIMENTAL
Intervention: Teriparatide
Number of subjects: 48
Study 26260784 — intervention group
Group type: COMPARATOR
Intervention: Alendronate
Number of subjects: 48
Study 26260784 — intervention group
Group type: COMPARATOR
Intervention: No medication
Number of subjects: 48
Study 25161026 — intervention group
Group type: EXPERIMENTAL
Intervention: Aminophylline
Number of subjects: 45
Study 25161026 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 22400174 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate disorders (group I)
Number of subjects: 112
Study 22400174 — intervention group
Group type: COMPARATOR
Intervention: Control group (group II)
Number of subjects: 112
Study 20478333 — intervention group
Group type: COMPARATOR
Intervention: Internet
Number of subjects: 481
Study 20478333 — intervention group
Group type: EXPERIMENTAL
Intervention: InPerson
Number of subjects: 481
Study 20478333 — intervention group
Group type: COMPARATOR
Intervention: Hybrid
Number of subjects: 481
Study 17826278 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital preoperative planning
Number of subjects: 210
Study 17826278 — intervention group
Group type: COMPARATOR
Intervention: Analogue preoperative planning
Number of subjects: 210
Study 11768839 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral tolterodine 2 mg BID (on days 1-14)
Number of subjects: 24
Study 11768839 — intervention group
Group type: COMPARATOR
Intervention: Low-dose combination oral contraceptive (ethinyl estradiol 30 microg/levonorgestrel 150 microg)
Number of subjects: 24
Study 9244152 — intervention group
Group type: EXPERIMENTAL
Intervention: AM‐C10 (ampicillin suppositories with sodium caprate)
Number of subjects: 12
Study 9244152 — intervention group
Group type: COMPARATOR
Intervention: AM (ampicillin suppositories without sodium caprate)
Number of subjects: 12
Study 8290903 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefpirome
Number of subjects: 378
Study 8290903 — intervention group
Group type: COMPARATOR
Intervention: Ceftazidime
Number of subjects: 378
Study 8290903 — intervention group
Group type: COMPARATOR
Intervention: Ceftriaxone
Number of subjects: 378
Study 3030089 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat diet
Number of subjects: 20
Study 3030089 — intervention group
Group type: COMPARATOR
Intervention: Low-fat diet
Number of subjects: 20
Study 29973307 — intervention group
Group type: EXPERIMENTAL
Intervention: Incentive (intervention plus incentive; CAD $5.00 e‐gift card delivered weekly for completing action plans over 4 weeks)
Number of subjects: 69
Study 29973307 — intervention group
Group type: EXPERIMENTAL
Intervention: Incentive (intervention plus incentive)
Number of subjects: 69
Study 29973307 — intervention group
Group type: COMPARATOR
Intervention: Control (intervention only)
Number of subjects: 69
Study 27871269 — intervention group
Group type: EXPERIMENTAL
Intervention: Institutionalization of postpartum intrauterine device (IUD) training as part of OB/GYN training programs in intervention hospitals.
Number of subjects: 0
Study 27871269 — intervention group
Group type: EXPERIMENTAL
Intervention: FIGO intervention for PPIUD training and integration into standard practice.
Number of subjects: 0
Study 27871269 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation of PPIUD services in study hospitals.
Number of subjects: 0
Study 27871269 — intervention group
Group type: EXPERIMENTAL
Intervention: Nested mixed-methods performance evaluation.
Number of subjects: 0
Study 26321559 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral plantar nerve release with calcaneal drilling (group 1, n=18)
Number of subjects: 33
Study 26321559 — intervention group
Group type: COMPARATOR
Intervention: Lateral plantar nerve release without calcaneal drilling (group 2, n=15)
Number of subjects: 33
Study 26321559 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral plantar nerve release with calcaneal drilling (group 1)
Number of subjects: 33
Study 26321559 — intervention group
Group type: COMPARATOR
Intervention: Lateral plantar nerve release without calcaneal drilling (group 2)
Number of subjects: 33
Study 23988242 — intervention group
Group type: EXPERIMENTAL
Intervention: Femtosecond laser-assisted lens fragmentation and anterior capsulotomy
Number of subjects: 119
Study 23988242 — intervention group
Group type: COMPARATOR
Intervention: Manual cataract surgery
Number of subjects: 119
Study 21170857 — intervention group
Group type: EXPERIMENTAL
Intervention: Open transvesical prostatectomy (OP)
Number of subjects: 100
Study 21170857 — intervention group
Group type: COMPARATOR
Intervention: Transurethral resection of the prostate (TURP)
Number of subjects: 100
Study 18799429 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress (public-speaking task)
Number of subjects: 25
Study 18799429 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 25
Study 16822128 — intervention group
Group type: EXPERIMENTAL
Intervention: Masked prime stimuli with short intervals
Number of subjects: 0
Study 16822128 — intervention group
Group type: EXPERIMENTAL
Intervention: Masked prime stimuli with long intervals
Number of subjects: 0
Study 16822128 — intervention group
Group type: EXPERIMENTAL
Intervention: Global-level priming effects
Number of subjects: 0
Study 16822128 — intervention group
Group type: EXPERIMENTAL
Intervention: Local-level effects
Number of subjects: 0
Study 12814613 — intervention group
Group type: EXPERIMENTAL
Intervention: Rofecoxib
Number of subjects: 0
Study 12814613 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 10634375 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 17
Study 10634375 — intervention group
Group type: COMPARATOR
Intervention: Recombinant human GH treatment (0.15 IU/kg x day for 1 week)
Number of subjects: 17
Study 8775589 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatment (encainide or flecainide)
Number of subjects: 1153
Study 8775589 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1153
Study 1295821 — intervention group
Group type: EXPERIMENTAL
Intervention: GH regimen of 15 IU/m2/week administered as a daily subcutaneous injection (26 males, 1 female)
Number of subjects: 52
Study 1295821 — intervention group
Group type: EXPERIMENTAL
Intervention: GH regimen of 30 IU/m2/week administered as a daily subcutaneous injection (20 males, 5 females)
Number of subjects: 52
Study 1295821 — intervention group
Group type: EXPERIMENTAL
Intervention: GH regimen of 25 IU/m2/week administered as a daily subcutaneous injection (16 short normal children, 9 males, 7 females)
Number of subjects: 52
Study 31955812 — intervention group
Group type: EXPERIMENTAL
Intervention: ICD implantation
Number of subjects: 252
Study 31955812 — intervention group
Group type: EXPERIMENTAL
Intervention: LGE presence
Number of subjects: 252
Study 31390305 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinect-based educational games (Fruits) played once a week for 5 weeks in addition to standard treatment
Number of subjects: 10
Study 31390305 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment only
Number of subjects: 10
Study 28690041 — intervention group
Group type: EXPERIMENTAL
Intervention: IV acetaminophen (1 g IV)
Number of subjects: 174
Study 28690041 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral acetaminophen (1 g oral)
Number of subjects: 174
Study 28690041 — intervention group
Group type: COMPARATOR
Intervention: Placebo (oral placebo and volume-matched IV normal saline)
Number of subjects: 174
Study 28690041 — intervention group
Group type: EXPERIMENTAL
Intervention: IV acetaminophen
Number of subjects: 174
Study 28690041 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral acetaminophen
Number of subjects: 174
Study 28690041 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 174
Study 25493970 — intervention group
Group type: EXPERIMENTAL
Intervention: High exposure antibiotic therapy (n = 604)
Number of subjects: 1200
Study 25493970 — intervention group
Group type: COMPARATOR
Intervention: Standard exposure antibiotic therapy (n = 596)
Number of subjects: 1200
Study 25493970 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (used for 3 days)
Number of subjects: 1200
Study 25493970 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (used for 1-2 days)
Number of subjects: 1200
Study 25493970 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin-containing regimens (first 3 days)
Number of subjects: 1200
Study 25083776 — intervention group
Group type: EXPERIMENTAL
Intervention: Loteprednol etabonate (LE)
Number of subjects: 118
Study 25083776 — intervention group
Group type: COMPARATOR
Intervention: Artificial tears (AT)
Number of subjects: 118
Study 21484454 — intervention group
Group type: EXPERIMENTAL
Intervention: Photogem® gel 50 mg/l (P50G)
Number of subjects: 60
Study 21484454 — intervention group
Group type: EXPERIMENTAL
Intervention: Photogem® gel 100 mg/l (P100G)
Number of subjects: 60
Study 21484454 — intervention group
Group type: EXPERIMENTAL
Intervention: Photogem® suspension 50 mg/l (P50S)
Number of subjects: 60
Study 21484454 — intervention group
Group type: EXPERIMENTAL
Intervention: Photogem® suspension 100 mg/l (P100S)
Number of subjects: 60
Study 20002742 — intervention group
Group type: EXPERIMENTAL
Intervention: Xeomin
Number of subjects: 300
Study 20002742 — intervention group
Group type: COMPARATOR
Intervention: Botox
Number of subjects: 300
Study 17892376 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene 60 mg daily for 5 years
Number of subjects: 10101
Study 17892376 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10101
Study 15939222 — intervention group
Group type: EXPERIMENTAL
Intervention: Clear diagnosis and reassurance that they would soon be better
Number of subjects: 128
Study 15939222 — intervention group
Group type: COMPARATOR
Intervention: Negative consultation with no clear diagnosis, advised to return if necessary
Number of subjects: 128
Study 12007554 — intervention group
Group type: EXPERIMENTAL
Intervention: Interviewer-administered questionnaire
Number of subjects: 234
Study 12007554 — intervention group
Group type: COMPARATOR
Intervention: Self-administered questionnaire
Number of subjects: 234
Study 10570754 — intervention group
Group type: EXPERIMENTAL
Intervention: Left prefrontal transcranial magnetic stimulation (TMS) for 2 weeks
Number of subjects: 22
Study 10570754 — intervention group
Group type: COMPARATOR
Intervention: Baseline measurements
Number of subjects: 22
Study 8759893 — intervention group
Group type: EXPERIMENTAL
Intervention: melphalan-prednisone + interferon alpha-2b (5 million units subcutaneously, 3 d/week)
Number of subjects: 583
Study 8759893 — intervention group
Group type: COMPARATOR
Intervention: melphalan-prednisone
Number of subjects: 583
Study 8759893 — intervention group
Group type: EXPERIMENTAL
Intervention: melphalan-prednisone + interferon alpha-2b
Number of subjects: 583
Study 1929687 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine gum
Number of subjects: 315
Study 1929687 — intervention group
Group type: COMPARATOR
Intervention: Placebo gum
Number of subjects: 315
Study 6414505 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 micrograms + 150 micrograms ethinyl oestradiol and levonorgestrel
Number of subjects: 142
Study 6414505 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 micrograms + 250 micrograms ethinyl oestradiol and levonorgestrel
Number of subjects: 142
Study 6414505 — intervention group
Group type: COMPARATOR
Intervention: Reference group using other contraceptive methods
Number of subjects: 142
Study 30312182 — intervention group
Group type: EXPERIMENTAL
Intervention: Alert group (received alerts for triple-low events)
Number of subjects: 7569
Study 30312182 — intervention group
Group type: COMPARATOR
Intervention: Nonalert group (did not receive alerts for triple-low events)
Number of subjects: 7569
Study 30312182 — intervention group
Group type: EXPERIMENTAL
Intervention: Alert group
Number of subjects: 7569
Study 30312182 — intervention group
Group type: COMPARATOR
Intervention: Nonalert group
Number of subjects: 7569
Study 27852953 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-week exercise programme
Number of subjects: 60
Study 27852953 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 60
Study 25336165 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral cefalexin
Number of subjects: 47
Study 25336165 — intervention group
Group type: COMPARATOR
Intervention: Parenteral cefazolin
Number of subjects: 47
Study 25336165 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral cefalexin and Parenteral cefazolin
Number of subjects: 47
Study 24333069 — intervention group
Group type: EXPERIMENTAL
Intervention: Cross-match-compatible platelets
Number of subjects: 31
Study 24333069 — intervention group
Group type: COMPARATOR
Intervention: Incompatible single donor platelet transfusions
Number of subjects: 31
Study 23193340 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation-based IPPE
Number of subjects: 28
Study 23193340 — intervention group
Group type: COMPARATOR
Intervention: Control group (hospital and specialty IPPEs)
Number of subjects: 28
Study 19615131 — intervention group
Group type: EXPERIMENTAL
Intervention: Xuebijing injection (100 ml twice a day for 7 days)
Number of subjects: 61
Study 17524720 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenteral nutrition (nitrogen and >or=10 kcal/kg/day of non‐protein calories for >or=5 days)
Number of subjects: 100
Study 17524720 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein-sparing therapy (nitrogen and fewer non‐protein calories)
Number of subjects: 100
Study 17524720 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenteral nutrition
Number of subjects: 100
Study 17524720 — intervention group
Group type: COMPARATOR
Intervention: No artificial nutrition (beyond regular food and/or standard (5%) dextrose)
Number of subjects: 100
Study 15177700 — intervention group
Group type: EXPERIMENTAL
Intervention: Hexarelin (4 x 50 microg)
Number of subjects: 7
Study 15177700 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 11397745 — intervention group
Group type: COMPARATOR
Intervention: Non-tailored letter
Number of subjects: 2553
Study 11397745 — intervention group
Group type: COMPARATOR
Intervention: Tailored letter
Number of subjects: 2553
Study 11397745 — intervention group
Group type: COMPARATOR
Intervention: No letter
Number of subjects: 2553